Retraction
Reduced expression of Jak-1 and Tyk-2 proteins leads to interferon resistance in hepatitis C virus replicon
Paper Information
Record ID:
65214
Author(s):
Journal:
Publication Date:
September 18, 2007
Retraction Date:
April 19, 2025
(<1 year years ago)
Subjects:
Institutions:
- Department of Pathology and Laboratory Medicine, Tulane University Health Sciences Center, 1430 Tulane Avenue, New Orleans, USA
- Microbiology and Immunology, Tulane University Health Sciences Center, 1430 Tulane Avenue, New Orleans, USA
- Medicine, Tulane University Health Sciences Center, 1430 Tulane Avenue, New Orleans, USA
- Surgery, Tulane University Health Sciences Center, 1430 Tulane Avenue, New Orleans, USA
- Department of Microbiology, Immunology and Parasitology, Louisiana State University Health Sciences Center, New Orleans, 70112, USA
- Louisiana State University-International Center of Medical Research and Training, University of Costa Rica, Costa Rica
Countries:
Article Type:
Publisher:
Springer - Biomed Central (BMC)
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (23)
23
Total Citations0
Post-Retraction23
Pre-Retraction0
Same DayLiver fibrosis in fish research: From an immunological perspective
Quanquan Cao, Hongying Shan, Zhao Ju et al. (10 authors)
Fish & Shellfish Immunology
Published: Jun 2023
6 citations
6 citations
683 days before retraction
Type-I interferon signatures in SARS-CoV-2 infected Huh7 cells
Xi Chen, Elisa Saccon, K. Sofia Appelberg et al. (11 authors)
Cell Death Discovery
Open Access
Published: May 2021
33 citations
33 citations
1432 days before retraction
Type-I interferon signatures in SARS-CoV-2 infected Huh7 cells
Xi Chen, Elisa Saccon, K. Sofia Appelberg et al. (11 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Feb 2021
6 citations
6 citations
1535 days before retraction
Hepatitis C Virus in mainland China with an emphasis on genotype and subtype distribution
Yu Zhang, Limin Chen, Miao He
Virology Journal
Open Access
Published: Feb 2017
78 citations
78 citations
2977 days before retraction
Anti-Hepatitis Virus Agents
Matthew Scherer, Chelsea Sammons, Brian Nelson et al. (5 authors)
ASM Press eBooks
Published: Mar 2016
3330 days before retraction
Distribution of HCV Genotypes in Patients of with Chronic Hepatitis C in the Eastern Anatolia Region
Osman Aktaş, Ahmet Özbek, Hakan Aydın et al. (4 authors)
Viral Hepatitis Journal
Open Access
Published: Dec 2014
10 citations
10 citations
3788 days before retraction
Paper citing Reduced expression of Jak-1 and Tyk-2 proteins lea...
Unknown Authors
Unknown Journal
Published: May 2014
3991 days before retraction
HCV Infection Selectively Impairs Type I but Not Type III IFN Signaling
Partha K. Chandra, Lili Bao, Kyoungsub Song et al. (13 authors)
American Journal Of Pathology
Open Access
Published: Nov 2013
63 citations
63 citations
4179 days before retraction
Identification of Alpha Interferon-Induced Envelope Mutations of Hepatitis C Virus <i>In Vitro</i> Associated with Increased Viral Fitness and Interferon Resistance
Stéphanie B. N. Serre, Henrik Krarup, Jens Bukh et al. (4 authors)
Journal of Virology
Open Access
Published: Sep 2013
28 citations
28 citations
4230 days before retraction
Isolation and characterization of interferon lambda-resistant hepatitis C virus replicon cell lines
Jacques Friborg, Baiqing Lin, Chaoqun Chen et al. (4 authors)
Virology
Open Access
Published: Jul 2013
2 citations
2 citations
4286 days before retraction
Hepatitis C virus targets the interferon‐α JAK/STAT pathway by promoting proteasomal degradation in immune cells and hepatocytes
Nigel J. Stevenson, Nollaig M. Bourke, Elizabeth J. Ryan et al. (9 authors)
FEBS Letters
Open Access
Published: Apr 2013
47 citations
47 citations
4390 days before retraction
CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c-jun N terminal kinase activation independent from the interferon pathway
Sibylle Rau, Eberhard Hildt, Kiyoshi Himmelsbach et al. (7 authors)
Hepatology
Published: Jul 2012
25 citations
25 citations
4656 days before retraction
Mechanism of HCV's resistance to IFN-α in cell culture involves expression of functional IFN-α receptor 1
Sibnarayan Datta, Sidhartha Hazari, Partha K. Chandra et al. (13 authors)
Virology Journal
Open Access
Published: Jul 2011
16 citations
16 citations
5028 days before retraction
Protein Pathway Activation Associated with Sustained Virologic Response in Patients with Chronic Hepatitis C Treated with Pegylated Interferon (PEG-IFN) and Ribavirin (RBV)
Zobair M. Younossi, Dolores Limongi, Maria Stepanova et al. (9 authors)
Journal of Proteome Research
Published: Dec 2010
11 citations
11 citations
5250 days before retraction
Correction: SH2 Modified STAT1 Induces HLA-I Expression and Improves IFN-γ Signaling in IFN-α Resistant HCV Replicon Cells
Bret Poat, Sidhartha Hazari, Partha K. Chandra et al. (9 authors)
PLoS ONE
Open Access
Published: Nov 2010
5 citations
5 citations
5267 days before retraction
Intracellular expression of IRF9 Stat fusion protein overcomes the defective Jak-Stat signaling and inhibits HCV RNA replication
Bret Poat, Sidhartha Hazari, Partha K. Chandra et al. (8 authors)
Virology Journal
Open Access
Published: Oct 2010
15 citations
15 citations
5303 days before retraction
SH2 Modified STAT1 Induces HLA-I Expression and Improves IFN-γ Signaling in IFN-α Resistant HCV Replicon Cells
Bret Poat, Sidhartha Hazari, Partha K. Chandra et al. (7 authors)
PLoS ONE
Open Access
Published: Sep 2010
12 citations
12 citations
5315 days before retraction
Polo-Like Kinase 1 Is Involved in Hepatitis C Virus Replication by Hyperphosphorylating NS5A
Yung‐Chia Chen, Wen‐Chi Su, Jingying Huang et al. (7 authors)
Journal of Virology
Open Access
Published: Jun 2010
78 citations
78 citations
5427 days before retraction
Impaired antiviral activity of interferon alpha against hepatitis C virus 2a in Huh-7 cells with a defective Jak-Stat pathway
Sidhartha Hazari, Partha K. Chandra, Bret Poat et al. (9 authors)
Virology Journal
Open Access
Published: Feb 2010
27 citations
27 citations
5546 days before retraction
Cellular models for the screening and development of anti-hepatitis C virus agents
Claire Gondeau, Lydiane Pichard‐Garcia, Patrick Maurel
Pharmacology & Therapeutics
Open Access
Published: Jun 2009
23 citations
23 citations
5778 days before retraction
Antiherpesvirus, Anti?Hepatitis Virus, and Anti?Respiratory Virus Agents
Michael T. Yin, James C. M. Brust, Hong‐Van Tieu et al. (4 authors)
Unknown Journal
Published: Feb 2009
8 citations
8 citations
5895 days before retraction
Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial
Tania M. Welzel, Timothy R. Morgan, Herbert L. Bonkovsky et al. (21 authors)
Hepatology
Open Access
Published: Feb 2009
81 citations
81 citations
5920 days before retraction
Metabolic syndrome, non‐alcoholic fatty liver disease and hepatitis C virus: impact on disease progression and treatment response
Zobair M. Younossi, Arthur J. McCullough
Liver International
Open Access
Published: Jan 2009
58 citations
58 citations
5925 days before retraction
Quick Stats
Total Citations:
23
Years Since Retraction:
<1 year
Open Access:
Yes
Last Checked:
Jul 23, 2025